Sulfonamide derivatives for the treatment of diseases

Details for Australian Patent Application No. 2005214154 (hide)

Owner Pfizer Inc.

Inventors Brown, Alan Daniel; Thomson, Nicholas Murray; Lane, Charlotte Alice Louise; Moses, Ian Brian; James, Kim

Agent Spruson & Ferguson

Pub. Number AU-B-2005214154

PCT Pub. Number WO2005/080324

Priority 04290168.6 22.01.04 EP; 0406388.9 22.03.04 GB; 60/600,259 09.08.04 US

Filing date 12 January 2005

Wipo publication date 1 September 2005

Acceptance publication date 24 January 2008

International Classifications

C07C 311/08 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 323/42 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 295/03 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/080324 Priority application(s): WO2005/080324

24 January 2008 Application Accepted

  Published as AU-B-2005214154

22 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214158-A process and capsule for preparing beverages

2005214153-Sulfonamide derivatives for the treatment of diseases